Aperam S.A.
APEMY · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $2,007 | $2,026 | $2,235 | $1,831 |
| - Cash | $376 | $239 | $185 | $216 |
| + Debt | $1,604 | $1,622 | $1,420 | $760 |
| Enterprise Value | $3,235 | $3,409 | $3,470 | $2,375 |
| Revenue | $1,648 | $1,654 | $1,658 | $1,471 |
| % Growth | -0.4% | -0.2% | 12.7% | – |
| Gross Profit | $1,410 | $1,654 | $1,658 | $1,471 |
| % Margin | 85.6% | 100% | 100% | 100% |
| EBITDA | $86 | $112 | $50 | $118 |
| % Margin | 5.2% | 6.8% | 3% | 8% |
| Net Income | -$25 | $19 | -$18 | $12 |
| % Margin | -1.5% | 1.1% | -1.1% | 0.8% |
| EPS Diluted | -0.34 | 0.25 | -0.25 | 0.16 |
| % Growth | -236% | 200% | -256.3% | – |
| Operating Cash Flow | $192 | $196 | -$105 | $172 |
| Capital Expenditures | -$20 | -$39 | -$54 | -$27 |
| Free Cash Flow | $172 | $157 | -$159 | $145 |